0001437749-23-025204.txt : 20230905
0001437749-23-025204.hdr.sgml : 20230905
20230905162818
ACCESSION NUMBER: 0001437749-23-025204
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230831
FILED AS OF DATE: 20230905
DATE AS OF CHANGE: 20230905
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Jason Drew
CENTRAL INDEX KEY: 0001821479
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 231236152
MAIL ADDRESS:
STREET 1: C/O UROGEN PHARMA LTD.
STREET 2: 400 ALEXANDER PARK DRIVE
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4
1
rdgdoc.xml
FORM 4
X0508
4
2023-08-31
0001668243
UroGen Pharma Ltd.
URGN
0001821479
Smith Jason Drew
400 ALEXANDER PARK DRIVE
PRINCETON
NJ
08540
1
General Counsel
0
Ordinary Shares
2023-08-31
4
M
0
8334
A
22207
D
Ordinary Shares
2023-08-31
4
S
0
3800
18.01
D
18407
D
Restricted Stock Units
2023-08-31
4
M
0
8334
0
D
Ordinary Shares
8334
0
D
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
The reporting person was granted RSUs on August 31, 2020 representing 25,000 ordinary shares. The RSUs vested in three equal installments on November 30, 2021, August 31, 2022 and August 31, 2023.
/s/ Jason D. Smith, Attorney-in-Fact
2023-09-05